Validation of the 70-gene signature test (MammaPrint) to identify patients with breast cancer aged ≥70 years with ultralow risk of distant recurrence: A population-based cohort study

被引：2
|
作者：
Mansani, Fabio P. [1 ]
Freitas-Junior, Ruffo [2 ]
机构：
[1] Univ Estadual Ponta Grossa, Ponta Grossa, PR, Brazil
[2] Univ Fed Goias, Goiania, Brazil
来源：
JOURNAL OF GERIATRIC ONCOLOGY | 2023年 / 14卷 / 05期
关键词：
Breast cancer; Endocrine therapy; Geriatric oncology; Genomic risk profile; Individualized treatment;
D O I：
10.1016/j.jgo.2023.101526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [11] The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancer
    J. Asher Jenkins
    Schelomo Marmor
    Jane Yuet Ching Hui
    Heather Beckwith
    Anne H. Blaes
    David Potter
    Todd M. Tuttle
    Breast Cancer Research and Treatment, 2022, 191 : 401 - 407
  • [12] The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancer
    Jenkins, J. Asher
    Marmor, Schelomo
    Hui, Jane Yuet Ching
    Beckwith, Heather
    Blaes, Anne H.
    Potter, David
    Tuttle, Todd M.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (02) : 401 - 407
  • [13] Comparison of risk prediction with the 21-gene recurrence score (oncotype DX) and the 70-gene signature (MammaPrint) in patients with estrogen receptor-positive early stage breast cancer
    Jiang, H.
    Denduluri, N.
    Majure, M.
    Favret, A.
    Rugo, H. S.
    CANCER RESEARCH, 2016, 76
  • [14] An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint®)
    Makama, M.
    Drukker, C. A.
    Rutgers, E. J. Th.
    Slaets, L.
    Cardoso, F.
    Rookus, M. A.
    Tryfonidis, K.
    Van't Veer, L. J.
    Schmidt, M. K.
    EUROPEAN JOURNAL OF CANCER, 2017, 75 : 5 - 13
  • [15] Equivalence of NGS-based MammaPrint 70-gene signature risk of recurrence and BluePrint 80-gene signature of molecular subtyping tests to the centralized microarray tests
    Schuler, E.
    Uygun, S.
    Mittempergher, L.
    Pronin, D.
    Mee, S.
    Bao, S.
    Cavness, T.
    Witteveen, A.
    Glas, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S232 - S232
  • [16] Comparison of the MammaPrint 70-Gene Expression Profile With Clinical Parameters in Patients With Breast Cancer: Findings From a United States Cohort
    Deck, Kenneth
    Kerlin, Deborah
    Barone, Julie L.
    Rivera, Edgardo
    Garcia, Agustin A.
    Sinha, Renu
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 : S166 - S166
  • [17] Depression subtypes and 5-years risk of mortality in aged 70 years: a population-based cohort study
    Vilalta-Franch, Joan
    Planas-Pujol, Xenia
    Lopez-Pousa, Secundino
    Llinas-Regla, Jordi
    Merino-Aguado, Javier
    Garre-Olmo, Josep
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2012, 27 (01) : 67 - 75
  • [18] Additional prognostic value of the 70-gene signature (MammaPrint®) among breast cancer patients with 4-9 positive lymph nodes
    Saghatchian, M.
    Mook, S.
    Pruneri, G.
    Viale, G.
    Glas, A. M.
    Guerin, S.
    Cardoso, F.
    Piccart, M.
    Tursz, T.
    Delaloge, S.
    van't Veer, L.
    BREAST, 2013, 22 (05): : 682 - 690
  • [19] Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature
    Johansson, Annelie
    Yu, Nancy Y.
    Iftimi, Adina
    Tobin, Nicholas P.
    't Veer, Laura
    Nordenskjold, Bo
    Benz, Christopher C.
    Fornander, Tommy
    Perez-Tenorio, Gizeh
    Stal, Olle
    Esserman, Laura J.
    Yau, Christina
    Lindstrom, Linda S.
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (12) : 2072 - 2082
  • [20] Obesity and the influence on tumor biology as determined by the intermediate risk 21-gene recurrence scores (RS) and the 70-gene breast cancer recurrence signature (70-GS) assay
    Robinson, P.
    Mai, H.
    Guo, R.
    Gaynor, E.
    McCroskey, Z.
    Ersahin, C.
    Albain, K.
    Lo, S.
    CANCER RESEARCH, 2013, 73
12345